Categories AlphaGraphs, Earnings, Health Care
JNJ Earnings: Key quarterly highlights from Johnson & Johnson’s Q4 2023 financial results
Johnson & Johnson (NYSE: JNJ) reported fourth quarter 2023 earnings results today.
Reported sales increased 7.3% year-over-year to $21.4 billion.
Net earnings increased 28% to $4.1 billion and EPS rose 39.3% to $1.70 from last year. Adjusted EPS rose 11.7% to $2.29.
Both revenue and earnings beat estimates.
For the full year of 2024, the company expects adjusted EPS of $10.55-10.75. Reported sales are expected to be $87.8-88.6 billion.
The stock stayed red during premarket hours on Tuesday.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
GIS Earnings: All you need to know about General Mills’ Q1 2025 earnings results
General Mills, Inc. (NYSE: GIS) reported its first quarter 2025 earnings results today. Net sales decreased 1% year-over-year to $4.8 billion. Organic sales were down 1%. Net earnings attributable to
Guardian Pharmacy seeks to raise up to $108 mil in US IPO
Joining the wave of healthcare IPOs this year, amid Fed rate cut expectations, Guardian Pharmacy Services, Inc. is preparing to go public. In a statement filed with the Securities and
Earnings Preview: Will Micron (MU) maintain recovery momentum in Q4?
After recovering from a rough patch, Micron Technology Inc. (NASDAQ: MU) is preparing to report fourth-quarter results next week, even as the market keeps a close watch on the event
